Related Experiment Video
Updated: Mar 21, 2026

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
Published on: June 29, 2021
Allergen immunotherapy in polysensitized patient
1Dept. Allergy & Clinical Immunology, Oncology Institute St. Elisabeth, Batislava, Slovakia. OKIA OÚSA, Heydukova 10 85103 Batislava, Slovakia Phone: +42 190 34 16 121 E-mail: martin.hrubisko@ousa.sk; mahrubisko@gmail.com.
Abstract:
Specific allergen immunotherapy (AIT) is the only therapeutic method with positive impact on natural course of allergic disease - affecting clinical development (including the progression of rhinitis to asthma) and new sensitisations. The actual problem is the increasing number of patients manifesting poly-sensitivity in allergy skin tests and / or in specific IgE tests. Usually, AIT is not recommended in such individuals. The objective we are facing is that in many patients tested as poly-reactive, we have to distinguish in which cases it is a true polysensitization, and when it is due to cross-reactivity of specific IgE antibodies induced by panallergens. This may really determine when AIT may be an appropriate course of action. The article focuses on this problem in more detail, applying the long time Czech and Slovak experience with allergy testing and allergen immunotherapy.
Related Concept Videos
Allergic Reactions
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Drug Toxicity: Allergic Reactions
Allergic Reactions: Anaphylaxis
Allergic Drug Reactions
Hypersensitivity Reactions: Immune-Complex Reactions

